Jazz Pharmaceuticals (JAZZ) Interest Coverage Ratio (2010 - 2013)

Jazz Pharmaceuticals' Interest Coverage Ratio history runs 17 years deep, the most recent figure standing at 0.58 for Q1 2026.

• In Q1 2026, Interest Coverage Ratio rose 756.44% year-over-year to 0.58; the TTM figure through Mar 2026 stood at 0.07 (down 106.92% YoY), while the FY2025 annual figure was 0.66, down 147.23% from the prior year.
• Interest Coverage Ratio for Q1 2026 stood at 0.58, down from 8.13 in the prior quarter.
• The five-year high for Interest Coverage Ratio was 23.19 in Q2 2024, with the low at 10.45 in Q4 2022.
• The 5-year median for Interest Coverage Ratio is 0.21 (2023), against an average of 1.35.
• The sharpest annual moves came in 2022 and 2024: Interest Coverage Ratio slumped 622.8% in 2022, then surged 8976.91% in 2024.
• Jazz Pharmaceuticals' Interest Coverage Ratio stood at 10.45 in 2022, then soared by 103.71% to 0.39 in 2023, then surged by 57.62% to 0.61 in 2024, then surged by 1232.21% to 8.13 in 2025, then tumbled by 92.85% to 0.58 in 2026.
• Business Quant data shows JAZZ's Interest Coverage Ratio at 0.58 in Q1 2026, 8.13 in Q4 2025, and 0.09 in Q3 2025.